Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Google

    - PMLiVE

    Lilly announces new study data on Inluriyo in metastatic breast cancer

    The five-year survival rate for metastatic breast cancer is 30%

    Amiculum's Aaron Fletcher smiling to camera on the left, with text on the right that reads 'AI persona generation'

    AI persona generation for healthcare: quick wins & real-world impact

    By Aaron Fletcher

    Amiculum

    VuuAI and Amiculum

    VuuAI and Amiculum partner to transform content engagement in pharma

    Amiculum, a global health communications agency, has entered into an exciting strategic collaboration with VuuAI, a GenAI-driven content production automation platform. The collaboration is designed to optimize the deployment of...

    Amiculum

    - PMLiVE

    Does real-world use of AI in systematic literature reviews result in time and cost savings?

    By Manca Povsic and Emma Griffiths

    Amiculum

    - PMLiVE

    Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

    Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

    Inizio

    - PMLiVE

    Gilead reports Trodelvy breast cancer trial missed primary survival endpoint

    The drug treatment is being evaluated in several ongoing phase 3 trials

    - PMLiVE

    Enhancing Medical Education through Gamification and Innovative Technologies

    One innovative approach that has gained traction in recent years is gamification—the integration of game elements such as points, leaderboards, and interactive elements into learning activities. Understanding gamification’s role in...

    Impetus Digital

    - PMLiVE

    Lilly reports survival benefit with Verzenio in high-risk early breast cancer

    The findings are based on Lilly’s phase 3 monarchE trial

    - PMLiVE

    Almirall and Absci expand AI dermatological drug discovery partnership

    The alliance has already led to the delivery of functional antibody leads against a difficult-to-drug target

    Is AI the answer? Translating complex medical information into public understanding

    By Rebecca Helson and Ben Clarke

    Amiculum

    Unlocking the future of Learning

    By Potter Li and Aaron Fletcher

    Amiculum

    - PMLiVE

    New Webinar: Supercharge Pharma Med Ed with AI

    Unlock the power of AI to transform pharma medical education, training, and critical insight gathering. Discover how next-gen AI tech such as AI Avatars, enable hyper-realistic training, enhance engagement, and...

    Impetus Digital

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links